Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans

被引:52
|
作者
Joukhadar, C
Stass, H
Müller-Zellenberg, U
Lackner, E
Kovar, F
Minar, E
Müller, M
机构
[1] Univ Vienna, Sch Med, Dept Internal Med 2, Div Angiol, Vienna, Austria
[2] Univ Vienna, Sch Med, Dept Clin Pharmacol, Div Clin Pharmacokinet, Vienna, Austria
[3] Bayer AG, Pharma Res Ctr, Inst Clin Pharmacol, D-5600 Wuppertal, Germany
关键词
D O I
10.1128/AAC.47.10.3099-3103.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The present study addressed the ability of moxifloxacin to penetrate into healthy and inflamed subcutaneous adipose tissues in 12 patients with soft tissue infections (STIs). Penetration of moxifloxacin into the interstitial space fluid of healthy and inflamed subcutaneous adipose tissues was measured by use of in vivo microdialysis following administration of a single intravenous dosage of 400 mg in six diabetic and six nondiabetic patients with STIs. For the entire study population, the mean time-concentration profile of free moxifloxacin in plasma was identical to the time-concentration profile of free moxifloxacin in tissue (P was not significant). For healthy and inflamed adipose tissues for the diabetic subgroup, the mean moxifloxacin areas under the concentration-time curves (AUCs) from 0 to 8 h (AUC(0-8)s) were 8.1 +/- 7.1 and 3.7 +/- 1.9 mg.h/liter, respectively (P was not significant). The ratios of the mean AUC(0-8) for inflamed tissue/AUC(0-8) for free moxifloxacin in plasma were 0.5 +/- 0.4 for diabetic patients and 1.2 +/- 0.8 for nondiabetic patients (P was not significant). The ratios of the AUCs from 0 to 24 h for free moxifloxacin in plasma/MIC at which 90% of isolates are inhibited were >58 and 121 h for Streptococcus species and methicillin-sensitive Staphylococcus aureus, respectively. Concentrations of moxifloxacin effective against clinically relevant bacterial strains are reached in plasma and in inflamed and healthy adipose tissues. Thus, the pharmacokinetics of moxifloxacin in tissue and plasma support its use for the treatment of STIs in diabetic and nondiabetic patients.
引用
收藏
页码:3099 / 3103
页数:5
相关论文
共 50 条
  • [1] Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans
    Joukhadar, C
    Stass, H
    Müller-Zellenberg, U
    Lackner, E
    Kovar, F
    Minar, E
    Müller, M
    [J]. PHARMACOLOGY, 2003, 69 (04) : 215 - 215
  • [2] HISTOLOGIC PROBE PENETRATION IN HEALTHY AND INFLAMED PERI-IMPLANT TISSUES
    LANG, NP
    WETZEL, AC
    STICH, H
    CAFFESSE, RG
    [J]. CLINICAL ORAL IMPLANTS RESEARCH, 1994, 5 (04) : 191 - 201
  • [3] Vitreal penetration of oral moxifloxacin in humans
    Lott, McGregor N.
    Fuller, Jeffrey J.
    Hancock, Heather A.
    Singh, Jasleen
    Singh, Harinderjit
    McGwin, Gerald
    Marcus, Dennis M.
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (03): : 473 - 476
  • [4] Moxifloxacin penetration into human gastrointestinal tissues
    Wirtz, M
    Kleeff, J
    Swoboda, S
    Halaceli, I
    Geiss, HK
    Hoppe-Tichy, T
    Büchler, MW
    Friess, H
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (05) : 875 - 877
  • [5] Penetration of moxifloxacin into peripheral compartments in humans
    Müller, M
    Stass, H
    Brunner, M
    Möller, JG
    Lackner, E
    Eichler, HG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (10) : 2345 - 2349
  • [6] Penetration of Doripenem into Skeletal Muscle and Subcutaneous Adipose Tissue in Healthy Volunteers
    Burian, Bernhard
    Zeitlinger, Markus
    Donath, Oliver
    Reznicek, Gottfried
    Sauermann, Robert
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (01) : 532 - 535
  • [7] Vitreous penetration of topical moxifloxacin and gatifloxacin in humans
    Costello, Patrick
    Bakri, Sophie J.
    Beer, Paul M.
    Singh, Ravinder J.
    Falk, Naomi S.
    Peters, George B.
    Melendez, J. Andre
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (02): : 191 - 195
  • [8] Vitreal penetration of oral and topical moxifloxacin in humans
    Fuller, Jeffrey J.
    Lott, McGregor N.
    Henson, Nathanael A.
    Bhatti, Asmaa A.
    Singh, Harinderjit
    McGwin, Gerald, Jr.
    Marcus, Dennis M.
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 143 (02) : 338 - 340
  • [9] Penetration of Moxifloxacin into heart tissues and vessel walls
    Schmid, F. X.
    Rupprecht, L.
    Floerchinger, B.
    Hilker, M.
    Kees, F.
    [J]. INFECTION, 2007, 35 : 64 - 64
  • [10] Distinct infrastructure of lipid networks in visceral and subcutaneous adipose tissues in overweight humans
    Zacharia, Anish
    Saidemberg, Daniel
    Mannully, Chanchal Thomas
    Kogan, Natalya M.
    Shehadeh, Alaa
    Sinai, Reut
    Zucker, Avigail
    Bruck-Haimson, Reut
    Goldstein, Nir
    Haim, Yulia
    Dani, Christian
    Rudich, Assaf
    Moussaieff, Arieh
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2020, 112 (04): : 979 - 990